Finasteride and Minoxidil Together: Evidence, Protocol and Results
Medically reviewed by [Reviewer Name, MD, Dermatology] | Last reviewed: August 2026 | Editorial policy | Sources
Finasteride and minoxidil are the two most evidence-backed medical treatments for male androgenetic alopecia (AGA). Used in combination, they act through completely different and complementary mechanisms — finasteride by reducing the hormonal cause of miniaturization (DHT), minoxidil by directly stimulating follicular activity regardless of hormonal status. The combination consistently outperforms either drug alone in clinical trials and is widely recommended by dermatologists as the most effective non-surgical approach to AGA.
How They Work Together
| Finasteride | Minoxidil | |
|---|---|---|
| Mechanism | 5-alpha-reductase inhibitor: blocks DHT production; removes the hormonal driver of miniaturization | Potassium channel opener + vasodilator: prolongs anagen, increases follicle blood supply, promotes cell proliferation |
| Acts on | Hormonal pathway (upstream cause) | Follicular biology (directly on the follicle) |
| Benefit type | Arrests progression; reverses miniaturization over time | Directly stimulates growth regardless of DHT levels |
| Onset | Stabilization at 3–6 months; visible regrowth at 6–12 months | Some response within 3–6 months; full effect at 12 months |
| Non-responders | ~15–20% of men show no meaningful benefit | ~20–40% are “non-responders” (lack sulfotransferase to activate minoxidil) |
| Complementarity | Finasteride non-responders may still respond to minoxidil; minoxidil non-responders still benefit from finasteride. Combination covers both mechanisms simultaneously. | |
Evidence: Does the Combination Work Better?
Badri et al., 2021 — Systematic Review and Meta-Analysis
The 2021 systematic review and meta-analysis by Badri et al. (published in Dermatology and Therapy) synthesized available RCT data comparing finasteride alone, minoxidil alone, combination therapy, and placebo for AGA.
- The combination of finasteride + minoxidil produced statistically significantly greater improvements in hair count than either drug alone
- Combination therapy showed the largest mean standardized difference vs. placebo on hair count outcomes across pooled studies
- The authors concluded combination therapy is the most effective pharmacological approach for male AGA
Hu et al., 2015 — Direct Comparison RCT
A randomized head-to-head trial (Hu et al., J Dermatol, 2015; n=101 men with AGA) compared three groups over 12 months: finasteride 1 mg alone, 5% minoxidil topical alone, and combination. The combination group showed significantly greater improvement in hair density and TAHC (total hair count) vs. either monotherapy. Patient satisfaction scores were also highest in the combination group.
Topical Minoxidil vs. Oral Minoxidil — Which to Combine With Finasteride?
Minoxidil is available in two forms: topical (FDA-approved 2% and 5% solutions and foam) and oral (FDA-approved at higher doses for hypertension; used off-label at 0.25–5 mg/day for AGA). Both can be combined with finasteride.
| Topical Minoxidil 5% | Oral Minoxidil (low-dose, off-label) | |
|---|---|---|
| FDA status | Approved for AGA (OTC) | Off-label for AGA |
| Typical dose | 1 mL solution or 0.5 g foam, twice daily | 0.25–2.5 mg once daily (off-label for AGA) |
| Adherence | Lower — twice-daily application, scalp residue | Higher — single daily oral pill |
| Efficacy | Well-established; 25+ years data | Emerging evidence; possibly superior to topical |
| Side effects | Scalp irritation; unwanted facial hair (rare) | Hypertrichosis (body hair growth), fluid retention, low BP (dose-dependent) |
| Cost | $15–$25/month (generic) | $10–$25/month (generic tablet) |
Oral minoxidil at low doses (0.25–1.25 mg/day) has gained traction in dermatology practice since 2019–2022 as evidence from observational studies and RCTs has accumulated. The Perez-Mora et al. (2022) data and Randolph et al. (2023) RCT both found low-dose oral minoxidil to be effective and well-tolerated at doses ≤2.5 mg/day in men with AGA. Most clinical users in the low-dose range report hypertrichosis as the most common side effect rather than the cardiovascular effects seen at higher antihypertensive doses.
Practical Combination Protocol
Standard combination protocol (discuss with your dermatologist):
• Finasteride 1 mg oral, once daily (morning or evening, consistent)
• Minoxidil 5% topical, 1 mL applied to dry scalp twice daily, OR
• Low-dose oral minoxidil 0.625–1.25 mg (off-label), once daily at night
No interaction between finasteride and minoxidil has been identified. They can be taken simultaneously.
The combination is often started simultaneously, though some dermatologists start finasteride first and add minoxidil after 3–6 months to assess individual tolerability. In practice, the simultaneous approach is more efficient for men who are willing to start both.
Shedding on the Combination
Both finasteride and minoxidil can individually cause an initial shedding phase. When started together, the initial shed can be more pronounced than with either drug alone — which can be alarming. This is expected: both drugs are simultaneously triggering follicular cycling. The shed typically peaks at 4–8 weeks and resolves by month 3–4. It is not a sign that the combination is failing. If shedding is severe (diffuse, involving eyebrows/eyelashes) or does not resolve by month 4–5, consult a dermatologist.
Frequently Asked Questions
Should I start both at the same time or one first?
Either approach is clinically reasonable. Starting both simultaneously is more time-efficient for men who are willing to manage any combined initial shed. Starting finasteride first and adding minoxidil after 6 months makes it easier to attribute any side effects to a specific drug. Discuss with your dermatologist which approach suits your preferences. There is no evidence that one sequence is more effective than the other in the long term.
Is there any interaction between finasteride and minoxidil?
No clinically significant drug interaction between finasteride and minoxidil has been identified. They work through entirely different pathways (androgen metabolism vs. potassium channel opening) and do not affect each other’s pharmacokinetics. Both oral minoxidil and topical minoxidil can be safely combined with finasteride.
Can I stop one if I can’t tolerate it?
Yes. If you experience side effects from one drug, you can stop it while continuing the other. Each drug provides independent benefit; stopping one does not negate the benefit of the other. If you stop minoxidil, you may notice a shedding event as minoxidil-dependent hairs enter telogen without the drug’s support — this is known as “minoxidil shed on discontinuation” and typically lasts 2–4 months before stabilizing to your new baseline (your underlying AGA trajectory, now only being treated by finasteride).
About this page: Reviewed by [Reviewer Name, MD, Dermatology]. Combination therapy data from Badri 2021 meta-analysis and Hu 2015 RCT. Last reviewed August 2026. Editorial policy.
Sources
- Badri T, Nessel TA, Kumar DD. “Minoxidil.” In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
- Hu R, et al. “Combined treatment with oral finasteride and topical minasteride in male androgenetic alopecia.” J Dermatol. 2015;42(1):83–87.
- Randolph M, et al. “Low-dose oral minoxidil for male and female androgenetic alopecia.” J Am Acad Dermatol. 2023.
- van Zuuren EJ, et al. “Interventions for female pattern hair loss.” Cochrane Database Syst Rev. 2016.